26 November 2021>: Articles
A New Potential Strategy for Acute Non-Alcoholic Steatohepatitis (NASH)
Unusual or unexpected effect of treatment
Anupamjeet Kaur Sekhon B* , Aniruddha Gollapalli E , Dharamjeet Kaur E , Bryan Janssen D , Mark L. Stevens E , Fernando Valerio A , Miguel A. Sierra-Hoffman EDOI: 10.12659/AJCR.932961
Am J Case Rep 2021; 22:e932961
Table 2. Liver function tests from initial diagnosis.
Date | ALP (30–101 U/L) | AST (9–40 U/L) | ALT (5–40 U/L) |
---|---|---|---|
05/06/2013 | 99 | 85 | 114 |
12/04/2017 | 54 | 22 | 39 |
03/05/2018 | 49 | 22 | 37 |
06/06/2018 | 42 | 21 | 28 |
12/12/2018 | 36 | 24 | 31 |
03/12/2019 | 42 | 24 | 27 |
04/16/2019 | 48 | 847 | 138 |
05/15/2019 | 80 | 117 | 146 |
09/13/2019 | 119 | 66 | 135 |
11/20/2019 | 99 | 110 | 254 |
12/04/2019 | 76 | 741 | 1862 |
12/10/2019 | 140 | 366 | 1251 |
01/07/2020 | 118 | 53 | 133 |
02/24/2020 | 83 | 42 | 42 |
03/26/2020 | 93 | 33 | 33 |
09/04/2020 | 107 | 42 | 70 |
10/09/2020 | 103 | 25 | 32 |